Breaking News Instant updates and real-time market news.

EMR

Emerson

$73.08

-0.435 (-0.59%)

, ETN

Eaton

$90.72

-1.09 (-1.19%)

08:43
11/19/19
11/19
08:43
11/19/19
08:43

Wolfe Research hosts company meetings at conference

Wolfe Research Hosted Company Meetings at PowerGen will be held in New Orleans on November 19.

EMR

Emerson

$73.08

-0.435 (-0.59%)

ETN

Eaton

$90.72

-1.09 (-1.19%)

FLOW

SPX FLOW

$45.99

-0.04 (-0.09%)

GE

General Electric

$11.41

-0.1 (-0.87%)

MCB

Metropolitan Bank

$45.50

-0.35 (-0.76%)

PH

Parker-Hannifin

$196.51

-0.08 (-0.04%)

SIEGY

Siemens

$0.00

(0.00%)

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 02

    Dec

  • 29

    Jan

EMR Emerson
$73.08

-0.435 (-0.59%)

11/06/19
COWN
11/06/19
DOWNGRADE
Target $72
COWN
Market Perform
Emerson downgraded to Market Perform from at Cowen
Cowen analyst Gutam Khanna downgraded Emerson to Market Perform from Outperform given its narrowing upside to its sum-of-the-parts valuation as well as a transition to 2020 that will limit potential for further upside. The analyst sees easing demand and emerging evidence of potential project slips of large greenfield projects given trade/geopolitical overhangs. Khanna maintained his $72 price target on Emerson shares.
11/14/19
HSBC
11/14/19
DOWNGRADE
Target $64
HSBC
Reduce
Emerson downgraded to Reduce from Hold at HSBC
HSBC analyst Puneet Garg downgraded Emerson Electric to Reduce from Hold with a $64 price target.
11/14/19
HSBC
11/14/19
DOWNGRADE
Target $64
HSBC
Reduce
HSBC downgrades Emerson to Reduce on slowing end markets
HSBC analyst Puneet Garg downgraded Emerson Electric to Reduce from Hold with a price target of $64, down from $66. The company reported "muted" Q4 sales and its margin missed expectations, Garg tells investors in a research note. The analyst expects a slowdown in Emerson's end markets to result in an earnings decline. He also believes the stock's valuation is "high" at current levels.
11/06/19
COWN
11/06/19
DOWNGRADE
Target $72
COWN
Market Perform
Emerson downgraded to Market Perform from Outperform at Cowen
Cowen analyst Gutam Khanna downgraded Emerson to Market Perform from Outperform with a $72 price target.
ETN Eaton
$90.72

-1.09 (-1.19%)

11/12/19
11/12/19
INITIATION

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. CSX (CSX) downgraded to Hold from Buy at Deutsche Bank. 2. Eaton (ETN) downgraded to Hold from Buy at HSBC. 3. Amneal Pharmaceuticals (AMRX) downgraded to Underweight from Neutral at JPMorgan with analyst Christopher Schott saying while some of the challenges facing the company appear fixable, like supply penalties and plant utilization, many appear fundamental, a function of the evolving dynamics in the U.S. generics market. 4. Albemarle (ALB) downgraded to Sector Perform from Outperform at RBC Capital with analyst Arun Viswanathan saying with lithium prices falling below historical levels, global lithium suppliers may have to reduce output and wait for demand to catch up. 5. Box (BOX) downgraded to Market Perform from Outperform at JMP Securities with analyst Erik Suppiger citing concerns that after the challenging October quarter, the pipeline of the company's business has slowed. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/12/19
HSBC
11/12/19
DOWNGRADE
Target $96
HSBC
Hold
Eaton downgraded to Hold from Buy at HSBC
HSBC analyst Puneet Garg downgraded Eaton to Hold from Buy with a $96 price target.
10/30/19
FBCO
10/30/19
NO CHANGE
Target $94
FBCO
Outperform
Eaton price target raised to $94 from $89 at Credit Suisse
Credit Suisse analyst John Walsh raised his price target for Eaton to $94 from $89 following the company's Q3 results, saying he thinks Eaton is "attractively" deploying capital via M&A and share repurchases. He maintains an Outperform rating.
10/16/19
10/16/19
UPGRADE
Target $95

Outperform
Eaton upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Christopher Glynn upgraded Eaton to Outperform from Perform with a price target of $95. The analyst believes that ten straight quarters of OM expansion, a well covered 3.5% dividend yield, and 8% 2019 free cash flow yield will prevail as more persuasive than some pending incremental cyclical pressures for long-term investors. Glynn also notes "strong price execution" at the Electrical segments, leveraging scale benefits of consolidation into channels.
FLOW SPX FLOW
$45.99

-0.04 (-0.09%)

08/13/19
GHSC
08/13/19
DOWNGRADE
GHSC
Neutral
SPX FLOW downgraded to Neutral from Buy at Seaport Global
08/13/19
GHSC
08/13/19
DOWNGRADE
GHSC
Neutral
SPX FLOW downgraded to Neutral on slowing end markets at Seaport Global
As previously reported, Seaport Global analyst Walt Liptak downgraded SPX FLOW to Neutral from Buy as he believes that the company will be impacted by sector slowing in its Food & Beverage and Industrial segments. In Q2, weak end markets continued to persist and he expects to see similar or worse than organic growth rates in the second half, Liptak tells investors. Additionally, SPX FLOW plans to divest a majority of the Power and Energy segment, but "timing is not on FLOW's side," said the analyst, who thinks the amount that the company can fetch for a business is expected to be lower than the average given the current environment for M&A valuations.
08/13/19
08/13/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pampa Energia (PAM) downgraded to Equal Weight from Overweight at Morgan Stanley and to Neutral from Buy at BofA/Merrill. 2. NextEra Energy (NEE) and Xcel Energy (XEL) downgraded to Equal Weight from Overweight at Barclays. 3. Seadrill (SDRL) downgraded to Neutral from Buy at BTIG with analyst Gregory Lewis saying the company emerged from bankruptcy with too much debt, and its options to increase liquidity are costlier today than they were last year owing to increasing concerns about the pace of the recovery of offshore drilling. 4. Occidental downgraded to Underweight from Neutral at JPMorgan with analyst Phil Gresh reinstated coverage of Occidental Petroleum following a period of restriction and downgraded the shares to Underweight from Neutral, saying despite the 33% stock price decline since before the Anadarko deal was announced, Occidental's total return potential of 15% is roughly half that of the peer group. 5. SPX Flow (FLOW) downgraded to Neutral from Buy at Seaport Global with analyst Walt Liptak saying he believes that the company will be impacted by sector slowing in its Food & Beverage and Industrial segments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/19
BUCK
11/04/19
NO CHANGE
Target $53
BUCK
Buy
SPX FLOW price target raised to $53 from $45 at Buckingham
Buckingham analyst Robert Barry raised his price target for SPX FLOW to $53 from $45 and reiterated a Buy rating following last wee's Q3 report. In a research note to investors, Barry says it was "good" to see further evidence of strong project and factory execution in Q3, with the outlook for margins in Food & Beverage, in particular, looking better for it. The analyst says he remains constructive on SPX FLOW shares, but thinks risk/reward is favorable here. He sees a "good chance" of a deal getting announced by end of year, as he believes the P&E sale process is at an advanced stage.
GE General Electric
$11.41

-0.1 (-0.87%)

11/13/19
JPMS
11/13/19
NO CHANGE
JPMS
Underweight
JPMorgan's Tusa disagrees with reasons behind GE share rally
Key to the recent bounce in shares of General Electric is the notion that management has set a bottom on fundamentals, with the company "raising" guidance a sign of change in the revision trajectory, JPMorgan analyst Stephen Tusa tells investors in a research note titled "'Geography' Lesson." The analyst, however, disagrees. Earnings headlines are a "small fraction of meaning when it comes to forward fundamentals," contends Tusa. He says GE is missing guidance on core business EBIT that was set in March, "the latest of anyone in the sector," with the 10% shortfall the most of any of the large caps. The analyst keeps an Underweight rating on General Electric.
11/04/19
LEHM
11/04/19
NO CHANGE
Target $12
LEHM
Overweight
Investors may start looking at GE with bull case becoming clearer, says Barclays
General Electric's Q3 contained "no nasty surprises" from legacy liabilities along with "some clear signs of progress amidst the house-cleaning," Barclays analyst Julian Mitchell tells investors in a research note. The analyst believes this will likely cause more long-term investors to start to take a closer look at GE during the second year of CEO Larry Culp's tenure. With GE's free cash flow bull case becoming clearer, long-term investors may start to take a look, says Mitchell. The analyst keeps an Overweight rating on General Electric shares with a $12 price target. The stock closed Friday up 40c to $10.38.
11/05/19
GABE
11/05/19
NO CHANGE
GABE
Buy
Gabelli recommends buying General Electric shares after Q3 report
Gabelli analyst Justin Bergner recommends buying General Electric shares following the company's Q3 report, which he said featured a "benign" insurance update as well as better than expected free cash flow and EPS guidance. He sees the report further reducing the potential for future negative surprises and "helping close the discount" to his unchanged $17 2020 Private Market Value. Bergner keeps a Buy rating on GE shares.
11/05/19
MSCO
11/05/19
NO CHANGE
Target $11
MSCO
Equal Weight
General Electric tail risk 'appears much smaller' after Q3, says Morgan Stanley
Morgan Stanley analyst Joshua Pokrzywinski said the significant tail risk from Long Term Care and pensions at General Electric "appears much smaller" after the "trimming of the tails" with its third quarter report. Having addressed the tail risk with a positive update on pension and LTC, the question then turns to how quickly can performance accelerate and while he sees the risk/reward "evolving more favorably," he also sees little change to core earnings power or secular growth. Pokrzywinski keeps an Equal Weight rating on GE shares and raised his price target on the stock to $11 from $10.
MCB Metropolitan Bank
$45.50

-0.35 (-0.76%)

PH Parker-Hannifin
$196.51

-0.08 (-0.04%)

11/18/19
LEHM
11/18/19
INITIATION
Target $227
LEHM
Overweight
Parker-Hannifin reinstated with an Overweight at Barclays
Barclays analyst Julian Mitchell reinstated coverage of Parker-Hannifin with an Overweight rating and $227 price target. The stock remains out of favor with the investment community, but the recent earnings report suggests "grounds for optimism," Mitchell tells investors in a research note. He believes a recovery has not yet been priced into U.S. Multi-Industry stocks.
11/05/19
BMOC
11/05/19
NO CHANGE
Target $210
BMOC
Outperform
Parker-Hannifin price target raised to $210 from $190 at BMO Capital
BMO Capital analyst Joel Tiss raised his price target on Parker-Hannifin to $210 and kept his Outperform rating after its Q3 results, saying that while the company beat on earnings, it cuts its FY20 EPS view to $10.10-$10.19 from $11.50-$12.30. The analyst notes that the guidance cut implies organic sales decline of 6% vs. 1.5% drop previously expected, but he remains bullish on the "bigger story" around the management's efforts to minimize cyclicality and improve profitability.
11/04/19
11/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BlackBerry (BB) upgraded to Neutral from Underperform at BofA/Merrill with analyst Daniel Bartus citing his updated sum-of-the-parts valuation model which, suggest limited downside at the current 2.2-times enterprise value to expected 2021 sales multiple vs. peer average multiple above 3-times. 2. Parker-Hannifin (PH) upgraded to Hold from Underperform at Gordon Haskett. 3. Oneok (OKE) upgraded to Buy from Neutral at Goldman Sachs with analyst Michael Lapides saying his estimates for 2020-2022 are 5% above consensus on average. 4. Hollysys (HOLI) upgraded to Buy from Neutral at Goldman Sachs with analyst Jacqueline Du saying the stock has dropped 21% year-to-date following the company's proposed placement to invest in Industrial Internet of Things in May. 5. Marvell (MRVL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Gary Mobley saying "we are at a 'tipping point' in adoption of Marvell's 5G system on chip and related Ethernet integrated circuits relative to 'expensive' field programmable gate arrays." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/19
GDHS
11/04/19
UPGRADE
GDHS
Hold
Parker-Hannifin upgraded to Hold from Underperform at Gordon Haskett
Gordon Haskett analyst John Inch upgraded Parker-Hannifin to Hold from Underperform saying last week's guidance cut "rebases expectations."
SIEGY Siemens
$0.00

(0.00%)

09/04/19
DBAB
09/04/19
UPGRADE
DBAB
Buy
Siemens upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Siemens to Buy from Hold with a price target of 105 euros.
09/25/19
HSBC
09/25/19
UPGRADE
HSBC
Buy
Siemens upgraded to Buy from Hold at HSBC
HSBC analyst Michael Hagmann upgraded Siemens to Buy from Hold and raised his price target for the shares to 120 euros from 114 euros.
09/25/19
HSBC
09/25/19
UPGRADE
HSBC
Buy
HSBC upgrades Siemens to Buy on potential 'Vision 2020+' changes
HSBC analyst Michael Hagmann upgraded Siemens to Buy from Hold and raised his price target for the shares to 120 euros from 114 euros. With its "Vision 2020+," the analyst believes that before the end of the next decade, Siemens will largely consist of the constituents of Digital Industries, Smart Infrastructure and IIoT related activities such as Mindsphere & Digital Services as well as Siemens Integration Services and separately listed Siemens Healthineers. The Powerhouse and Mobility will just like Infineon become completely separate companies over time, Hagmann tells investors in a research note. He sees the Powerhouse spinoff as creating a "more focused group and an important medium-term catalyst."
09/25/19
09/25/19
UPGRADE

Fly Intel: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Berry Global (BERY) upgraded to Buy on valuation at BofA/Merrill with analyst George Staphos saying he thinks the shares now reflect "a pessimistic, mid-single digit perpetuity decline rate" and concerns on plastics that have been a headwind for sector multiples. 2. Toll Brothers (TOL), Lennar (LEN), and KB Home (KBH) upgraded to Outperform from Market Perform at Raymond James. 3. BancorpSouth (BXS) upgraded to Buy from Hold at SunTrust with analyst Jennifer Demba saying she is positive on the company's "steady" small bank acquisition strategy and its "less asset sensitive" balance sheet, adding that its large mortgage and insurance business help to offset the interest rate related challenges in spread income. 4. Siemens (SIEGY) upgraded to Buy from Hold at HSBC with analyst Michael Hagmann saying with its "Vision 2020+," he believes that before the end of the next decade, Siemens will largely consist of the constituents of Digital Industries, Smart Infrastructure and IIoT related activities such as Mindsphere & Digital Services as well as Siemens Integration Services and separately listed Siemens Healthineers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MGTA

Magenta Therapeutics

$12.99

-0.14 (-1.07%)

05:03
12/06/19
12/06
05:03
12/06/19
05:03
Initiation
Magenta Therapeutics initiated  »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

ODT

Odonate Therapeutics

$33.29

-1.75 (-4.99%)

05:02
12/06/19
12/06
05:02
12/06/19
05:02
Initiation
Odonate Therapeutics initiated  »

Odonate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNSA

Kiniksa

$10.01

-0.1 (-0.99%)

05:00
12/06/19
12/06
05:00
12/06/19
05:00
Upgrade
Kiniksa rating change  »

Kiniksa assumed to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$165.41

-1.22 (-0.73%)

04:58
12/06/19
12/06
04:58
12/06/19
04:58
Initiation
Amedisys initiated  »

Amedisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.09

-0.49 (-1.05%)

04:56
12/06/19
12/06
04:56
12/06/19
04:56
Downgrade
Sanofi rating change  »

Sanofi downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

CDEV

Centennial Resource Development

$3.41

0.06 (1.79%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Centennial Resource Development rating change  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$3.93

-0.135 (-3.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$65.77

-0.15 (-0.23%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Cadence Design management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SPGI

S&P Global

$271.33

2.81 (1.05%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
S&P Global management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Jan

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Healthcare Analysts…

FTNT

Fortinet

$104.92

1.37 (1.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Fortinet management to meet with Oppenheimer »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

  • 08

    Jan

KMPR

Kemper

$73.65

-0.76 (-1.02%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Kemper management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

  • 12

    Dec

EXTR

Extreme Networks

$6.80

-0.08 (-1.16%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Extreme Networks management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 10

    Dec

AXP

American Express

$118.31

0.32 (0.27%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
American Express management to meet with William Blair »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

OPRT

Oportun Financial

$20.13

0.11 (0.55%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Oportun Financial management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

, CBM

Cambrex

$59.99

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Hot Stocks
Industrial Logistics Property to replace Cambrex in S&P 600 at open on 12/6 »

Permira Advisors is…

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

CBM

Cambrex

$59.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNLO

Menlo Therapeutics

$4.20

0.2 (5.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Menlo Therapeutics management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MELI

MercadoLibre

$578.24

3.3 (0.57%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
MercadoLibre management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 17

    Dec

  • 17

    Dec

DSGX

Descartes Systems

$40.85

-1.59 (-3.75%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Descartes Systems management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MPWR

Monolithic Power

$162.23

0.24 (0.15%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Monolithic Power management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ENLAY

Enel

$0.00

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Enel management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

WNC

Wabash

$15.51

0.17 (1.11%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wabash management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Macquarie to hold a conference »

Asia Internet, Media and…

AZPN

Aspen Technology

$120.26

-0.95 (-0.78%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

AAON

AAON

$49.14

0.78 (1.61%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
AAON management to meet with Sidoti »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.